Mercy BioAnalytics, Inc.

Biotechnology company · Natick, Massachusetts, United States

Mercy BioAnalytics, Inc. is a biotechnology company headquartered in Natick, Massachusetts, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $27 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Mercy BioAnalytics at a glance

Typebiotechnology company

HeadquartersNatick, Massachusetts, United States

Earliest incorporation on record2018

SEC CIK1842887

What does Mercy BioAnalytics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $27.3 million sold (2021).

Frequently asked questions about Mercy BioAnalytics

Where is Mercy BioAnalytics headquartered?

Mercy BioAnalytics, Inc. is headquartered in Natick, Massachusetts, United States.

What does Mercy BioAnalytics do?

Mercy BioAnalytics, Inc. is a biotechnology company.

When was Mercy BioAnalytics founded?

The earliest incorporation on record for Mercy BioAnalytics, Inc. is in 2018, according to public company registers.

Similar companies

AutoIVF, Inc.Natick, Massachusetts, United States
NeuroDex IncNatick, Massachusetts, United States
Bridge 12 Technologies, Inc.Natick, Massachusetts, United States
Helios Cardio Inc.Natick, Massachusetts, United States
PIC Therapeutics, Inc.Natick, Massachusetts, United States
Emit Imaging, Inc.Natick, Massachusetts, United States
Aleta Biotherapeutics, Inc.Natick, Massachusetts, United States
Recursion PharmaceuticalsSalt Lake City, Utah, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences